3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
15
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Colorectal Neoplasms
3
Multiple Myeloma
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Polycythemia Vera
1
Parkinsonian Disorders
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
High Grade Neuroendocrine Neoplasms
1
Interventions
Paclitaxel
134
Carboplatin
129
Bevacizumab
86
Gemcitabine
45
pembrolizumab
37
olaparib
33
Cisplatin
30
liposomal doxorubicin
29
Docetaxel
29
Cyclophosphamide
29
Topotecan
28
niraparib
27
Taxes
20
Etoposide
18
Filgrastim
16
Doxorubicin
16
Immunoglobulin G
15
Disulfides
15
apatinib
12
Letrozole
12
Albumin-Bound Paclitaxel
12
Drug Therapy
11
fluzoparib
10
fludarabine
10
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Biopsy
10
durvalumab
9
Nivolumab
9
pazopanib
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Ovarian Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT01333748
2012-07-13
EXSAL
Centre Francois Baclesse
Phase 2
Completed
530 enrolled